A primer on the economics of re-importation of prescription drugs

Article Abstract:

The implications of shifting from differential to standardized global pricing of prescription drugs on profitability of the global pharmaceutical indusrty is analyzed. It was investigated that the global pricing would have greater effects on Canada, Asia, and Europe than on the United States. The possibility that these regions would demand for lower prices as a consequence of uniform pricing is examined.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

'Branded generics' as a strategy to limit cannibalization of pharmaceutical markets

Article Abstract:

Pharmaceutical companies introduce generic versions of their patented drugs to manipulate the balance in market share between generics and brand drugs. The strategy is to sell the generics at a high price, influencing consumers to buy the branded ones instead, which in turn, increases revenue for the company in the branded segment. The implications of branded generic technique are evaluated.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Uncertainty and choice: the challenges of pharmaceutical efficacy, safety, and cost

Article Abstract:

The price hike in healthcare and particularly that in medicine is allegedly caused by fewer new drugs that are being developed. Safety is another issue being faced by the industry as government agencies are speeding up approvals at the expense of therapeutic benefits. The importance of monitoring the effects of the approved medicines is discussed.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: